From 2023 through 2028, the sales of musculo-skeletal system medicines in the UK show a steady increase, with an annual uptick of around 0.9% to 1%. This suggests a consistent rise in demand and potential growth in the market for these medicines. The growth pattern is stable with a Compound Annual Growth Rate (CAGR) expected to maintain this trend over the five-year period, starting from 2023's baseline actual data.

Future trends to watch for:

Innovations in musculo-skeletal treatments could drive higher demand and market adjustments.
Potential shifts in healthcare policy or economic conditions could impact spending per capita.
Technological advancements and alignment with aging population health needs might alter growth projections.